Radiosensitization by 5-fluorocytosine of human colorectal carcinoma cells in culture transduced with cytosine deaminase gene

Clinical Cancer Research

Volumn 2, Issue 1, 1996, Pages 53-57

  Khil, Mark S ^a   Kim, Jae Ho ^a   Mullen, Craig A ^b   Kim, Sang Hie ^a   Freytag, Svend O ^a  

^a HENRY FORD HOSPITAL   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOSINE DEAMINASE; FLUCYTOSINE; FLUOROURACIL;

ARTICLE; CANCER CELL CULTURE; COLORECTAL CANCER; CONTROLLED STUDY; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RADIOSENSITIZATION;

CELL SURVIVAL; COLORECTAL NEOPLASMS; COMBINED MODALITY THERAPY; CYTOSINE DEAMINASE; FLUCYTOSINE; GENE THERAPY; GENE TRANSFER TECHNIQUES; HUMANS; NUCLEOSIDE DEAMINASES; RADIATION-SENSITIZING AGENTS; TUMOR CELLS, CULTURED;

EID: 0030052050     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Kilstrup, M., Meng, L. M., Neuhard, J., and Nygaard, P. Genetic evidence for a repressor of synthesis of cytosine deaminase and purine biosynthesis enzymes in Escherichia coli. J. Bacteriol., 171: 2124-2127, 1989.
2. Andersen, L., Kilstrup, M., and Neuhard, J. Pyrimidine, purine and nitrogen control of cytosine deaminase synthesis in Escherichia coli K12, Involvement of the glnLG and purR genes in the regulation of codA expression. Arch. Microbiol., 152: 115-118, 1989.
3. Polak, A., and Scholer, H. J. Mode of action of 5-fluorocytosine and mechanisms of resistance. Chemotherapy, 21: 113-130, 1975.
4. 14C in mouse, rat, rabbit, dog and man. Chemotherapy, 22: 137-153, 1976.
5. 14C in man. Biochem. Pharmacol., 15: 435-446, 1966.
6. Mullen, C. A., Kilstrup, M., and Blaese, R. M. Transfer of the bacterial gene for cytosine deaminase to mammalian cells confers lethal sensitivity to 5-fluorocytosine: a negative selection system. Proc. Natl. Acad. Sci. USA, 89: 33-37, 1992.
7. Mullen, C. A., Coale, M. M., Lowe, R., and Blaese, R. M. Tumors expressing the cytosine deaminase suicide gene can be eliminated in vivo with 5-fluorocytosine and induce protective immunity to wild-type tumor. Cancer Res., 54: 1503-1506, 1994.
8. Huber, B. E., Austin, E. A., Good, S. S., Knick, V. C., Tibbels, S., and Richards, C. A. In vivo antitumor activity of 5-fluorocytosine on human colorectal carcinoma cells genetically modified to express cytosine daminase. Cancer Res., 53: 4619-4626, 1993.
9. Austin, E. A., and Huber, B. E. A first step in the development of gene therapy for colorectal carcinoma: cloning, sequencing, and expression of Escherichia coli cytosine deaminase. Mol. Pharmacol., 43: 380-387, 1993.
10. Albrignt, N. W. Computer program for further analysis of cell survival data. Radiat. Res., 112: 331-340, 1987.
11. Huber, B. E., Austin, E. A., Richards, C. A., and Davis, S. T. Metabolism of 5-fluorocytosine to 5-fluorouracil in human colorectal tumor cells transduced with the cytosine deaminase gene: Significant antitumor effects when only a small percentage of tumor cells express cytosine deaminase. Proc. Natl. Acad. Sci. USA, 91: 8302-8306, 1994.
12. Domin, B. A., Mahony, W. B., and Zimmerman, T. P. Purine nucleobase transport in human erythrocytes. J. Biol. Chem., 263: 9276-9284, 1988.
13. Parker, W. B., and Cheng, Y. C. Metabolism and mechanism of action of 5-fluorouracil. Pharmacol. Ther., 48: 381-395, 1990.
14. Weckbecker, G Biochemical pharmacology and analysis of fluoropyrimidines alone and in combination with modulators. Pharmacol. Ther., 50: 367-424, 1991.
15. Byfield, J. E. Combined use of drugs and radiation in the treatment of liver metastases. Recent Results Cancer Res., 700: 298-306, 1986.
16. Byfield, J. E., Calabro-Jones, P., Klisak, I., and Kulhanian, F. Pharmacologic requirements for obtaining sensitization of human tumor cells in vitro to combined 5-fluorouracil or ftorafur and x-rays. Int. J. Radiat. Oncol. Biol. Phys., 8: 1923-1933, 1982.
17. von der Maase, H. Experimental studies on interactions of radiation and cancer chemotherapeutic drugs in normal tissues and a solid tumour. Radiother. Oncol., 7: 47-68, 1986.
18. Mini E., Mazzei, T., Coronnello, M., Criscuoli, L., Gualtieri, M., Penti, P., and Bertino, J. R. Effects of 5-methyltetrahydrofolate on the activity of fluoropyrimidines against human leukemia (CCRF-CEM) cells. Biochem. Pharmacol., 36: 2905-2911, 1987.
19. Smalley, S. R., Kimler, B. F., and Evans, R. G. 5-fluorouracil modulation of radiosensitivity in cultured human carcinoma cells. Int. J. Radiat. Oncol. Biol. Phys , 20: 207-211, 1991.
20. Bruso, C. E., Shewach, D. S., and Lawrence, T. S. Fluorodeoxyuridine induced radiosensitization and inhibition of DNA double strand break repair in human colon cancer cells. Int. J. Radiat. Oncol. Biol. Phys., 19: 1411-1417, 1990.
21. Moran, R. G. Leucovorin enhancement of the effects of the fluoropyrimidines on thymidylate synthase. Cancer. (Phila.), 63: 1008-1012, 1989.
22. Lönn, U., and Lönn, S. Increased levels of DNA lesions induced by leucovorin-5-fiuoropyrimidine in human colon adenocarcinoma. Cancer Res., 48: 4153-4157, 1988.
23. Park, J. G., Collins J. M., Gazdar, A. F., Allegra, C. J., Steinberg, S. M., Greene, R. F., and Kramer, B. S. Enhancement of fluorinated pyrimidine induced cytotoxicity by leucovorin in human colorectal carcinoma cell lines. J. Natl. Cancer Inst., 80: 1560-1564, 1988.
24. Arbuck, S. Overview of clinical trials using 5-fluorouracil and leucovorin for the treatment of colorectal cancer. Cancer, (Phila.), 63: 1036-1044, 1989.
25. Weichselbaum, R. R., Hallahan, D. H., Sukhatme, V. P., and Kufe, D. W. Gene therapy targeting by ionizing radiation. Int. J. Radiat. Oncol. Biol. Phys., 24: 565-567, 1992.
26. Kim, J. H., Kim, S. H., Brown S. L., and Freytag, S. O Selective enhancement by an antiviral agent of the radiation induced cell killing of human glioma cells transduced with HSV-tk gene. Cancer Res., 54: 6053-6056, 1994.
27. Emerman, M., and Temin, H. M. Genes with promoters in retrovirus vectors can be independently suppressed by an epigenetic mechanism. Cell. 39: 459-467, 1984.
28. Freytag, S. O., and Collier, K. J. Molecular cloning of a cDNA for human pyravate carboxylase. J. Biol. Chem., 259: 12831-12837, 1984.
29. Freytag, S. O., Parelli, D. L., and Gilbert, J. D. Ecotopic expression of the CCAAT/enhancer binding protein ∞ promotes the adipogenic program in a variety of mouse fibroblastic cells. Gene & Dev., 8: 1654-1663, 1994.